Answers are grounded in this paper and cite their sources.
Background Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a major cause of morbidity and mortality in systemic sclerosis (SSc), but its clinical course is heterogeneous. Early identification of patients at risk for pulmonary deterioration remains a major clinical challenge. Nailfold videocapillaroscopy (NVC) is a non-invasive method for evaluating SSc microangiopathy and may have prognostic value for pulmonary outcomes. Objective To systematically review and narratively synthesize evidence on whether baseline or longitudinal NVC abnormalities predict incident ILD, ILD progression, pulmonary function decline, or radiographic worsening in SSc. Methods A systematic literature review and narrative synthesis was structured according to PRISMA 2020 principles, using PubMed/MEDLINE, Europe PMC, the Cochrane Library, Google Scholar screening, reference-list checking, forward citation tracking, and hand-searching of key rheumatology and scleroderma journals. Eligible studies included adults with SSc, NVC or nailfold capillaroscopy assessment, and pulmonary outcomes related to ILD, FVC, DLCO, HRCT findings, or broader cardiopulmonary/severe organ progression. Due to heterogeneity in study design, NVC scoring and pulmonary endpoints, a narrative synthesis was performed rather than meta-analysis. Results Eighteen original studies were included in the qualitative synthesis, including nine longitudinal/prognostic studies and nine cross-sectional or diagnostic-supportive studies. The strongest ILD-specific evidence came from recent longitudinal cohorts. In one prospective longitudinal study, baseline capillary disorganization predicted greater decline in FVC and DLCO over two years, while a late NVC pattern was associated with DLCO decline and increasing KL-6. In a large EUSTAR analysis of early SSc patients without ILD at baseline, baseline NVC pattern alone did not predict five-year incident ILD, but annual worsening/transition of NVC pattern was strongly associated with incident ILD. Cross-sectional evidence consistently associated capillary loss, avascular areas, low capillary density, active/late patterns and higher NVC severity with prevalent ILD, lower FVC or DLCO, or greater radiographic disease burden. Conclusion NVC is a promising complementary marker for pulmonary risk stratification in SSc, particularly when quantitative capillary loss, architectural disorganization and serial worsening are considered. However, the evidence is not yet sufficient to support NVC as a standalone predictor of SSc-ILD progression. Future multicenter longitudinal studies should standardize NVC acquisition, quantitative scoring, HRCT/PFT timing and progression definitions, and should test NVC within multivariable prediction models alongside clinical phenotype, autoantibodies, HRCT extent and baseline PFTs.
No takes yet. Share an insight, caveat, or question.
Bogojević et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: